Rankings
▼
Calendar
ORGO FY 2025 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$355M
FY 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$564M
+17.0% YoY
Gross Profit
$415M
73.6% margin
Operating Income
$56M
10.0% margin
Net Income
$37M
6.6% margin
EPS (Diluted)
$0.15
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$24M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$599M
Total Liabilities
$165M
Stockholders' Equity
$434M
Cash & Equivalents
$94M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$564M
$482M
+17.0%
Gross Profit
$415M
$366M
+13.3%
Operating Income
$56M
-$1M
+4494.8%
Net Income
$37M
$861,000
+4201.0%
← Q4 2024
All Quarters
Q1 2025 →